$4.24
-0.11-2.53%
At close: May 15, 5:00 PM EST
$4.24
N/A
After Hours: May 15, 4:00 PM EST
Arbutus Biopharma Corp Earnings Estimates
ABUSNASDAQ
Earnings: Q1 2026 Earnings were released on Wed May 13th, before the market open
Arbutus Biopharma Earnings Estimates, EPS & Revenue | NASDAQ:ABUS
Arbutus Biopharma (ABUS) is scheduled to report Q2 earnings on August 5, 2026. Analysts estimate EPS of $-0.06 and quarterly revenue of $961.00K.
In the most recent quarter (Q1), Arbutus Biopharma reported EPS of $0.87, beating estimates of $-0.06 by 15.50%. Revenue came in at $179.13M, exceeding the estimate of $1.53M by 116.00%.
Arbutus Biopharma has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Arbutus Biopharma has averaged an EPS surprise of 4.35% and a revenue surprise of 30.28%.
Earnings Date
Aug 5
EPS Estimate
$-0.060
Quarterly Revenue Estimate
$961.00K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$191.44M
Arbutus Biopharma Earnings History
Analyze the earnings history of Arbutus Biopharma using advanced sorting and filters.
Loading calendar...
Arbutus Biopharma (ABUS) Earnings Per Share
The chart below shows Arbutus Biopharma's reported EPS compared to analyst estimates over recent quarters.
Arbutus Biopharma (ABUS) Revenue
The chart below shows Arbutus Biopharma's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Arbutus Biopharma (NASDAQ:ABUS) reporting earnings?
Arbutus Biopharma (ABUS) is scheduled to report earnings on August 5, 2026. The last reported earnings were for reported on May 13, 2026 for Q1.
What were the latest earnings per share (EPS) for Arbutus Biopharma (NASDAQ:ABUS)?
The Actual EPS was $0.87, which beat the estimate of $-0.06.
What were Arbutus Biopharma’s (NASDAQ:ABUS) revenues?
The Actual Revenue was $179.13M, which beat the estimate of $1.53M.
